Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).
Breast Cancer. 2023 Nov;30(6):943-951. doi: 10.1007/s12282-023-01485-y. Epub 2023 Jul 24.
Breast Cancer. 2023.
PMID: 37486454
Free PMC article.
Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Iwata H, Masuda N, Yamamoto D, Sagara Y, Sato N, Yamamoto Y, Saito M, Fujita T, Oura S, Watanabe J, Tsukabe M, Horiguchi K, Hattori S, Matsuura Y, Kuroi K.
Iwata H, et al. Among authors: tsukabe m.
Breast Cancer Res Treat. 2017 Apr;162(3):501-510. doi: 10.1007/s10549-017-4138-3. Epub 2017 Feb 8.
Breast Cancer Res Treat. 2017.
PMID: 28181129
Item in Clipboard
Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.
Tsukabe M, Shimazu K, Morimoto K, Naoi Y, Kagara N, Shimoda M, Shimomura A, Maruyama N, Kim SJ, Noguchi S.
Tsukabe M, et al.
Oncology. 2013;85(4):248-56. doi: 10.1159/000355476. Epub 2013 Oct 29.
Oncology. 2013.
PMID: 24192633
Item in Clipboard
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR.
Hashimoto Y, Masunaga N, Kagara N, Abe K, Yoshinami T, Tsukabe M, Sota Y, Miyake T, Tanei T, Shimoda M, Shimazu K.
Hashimoto Y, et al. Among authors: tsukabe m.
Cancers (Basel). 2023 May 6;15(9):2632. doi: 10.3390/cancers15092632.
Cancers (Basel). 2023.
PMID: 37174098
Free PMC article.
Item in Clipboard
Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer.
Shimoda M, Sato Y, Abe K, Masunaga N, Tsukabe M, Yoshinami T, Sota Y, Miyake T, Tanei T, Shimazu K.
Shimoda M, et al. Among authors: tsukabe m.
Oncol Lett. 2024 Apr 5;27(6):250. doi: 10.3892/ol.2024.14383. eCollection 2024 Jun.
Oncol Lett. 2024.
PMID: 38638841
Free PMC article.
Item in Clipboard
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer.
Tanei T, Seno S, Sota Y, Hatano T, Kitahara Y, Abe K, Masunaga N, Tsukabe M, Yoshinami T, Miyake T, Shimoda M, Matsuda H, Shimazu K.
Tanei T, et al. Among authors: tsukabe m.
Cancers (Basel). 2024 Mar 5;16(5):1062. doi: 10.3390/cancers16051062.
Cancers (Basel). 2024.
PMID: 38473420
Free PMC article.
Item in Clipboard
[The Implications of Primary Tumor Resection during Recent Chemotherapy of Unresectable Colon Cancer].
Ohnishi T, Fujie Y, Nonaka R, Nishida K, Tsukabe M, Hashimoto K, Fujita S, Fujita JY, Imaoka S, Yoshida T.
Ohnishi T, et al. Among authors: tsukabe m.
Gan To Kagaku Ryoho. 2015 Nov;42(12):1524-6.
Gan To Kagaku Ryoho. 2015.
PMID: 26805084
Japanese.
Item in Clipboard
Cite
Cite